Biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products
Ended Purchase Order Awarded Last action
- Contract number
- 75N95024P00130
- Awardee
-
RPK Associates, LLC UEI LVQSZ4JZE4V3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $67,500
Award facts
- Opportunity
-
- Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Cell and Gene Therapy Products Solicitation · 75N95024Q00081 · Posted Jan 4, 2024
- Contract value 28% obligated
-
- $67,500.00 Current, with exercised options
- $244,800.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Brookeville, MD 20833, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $36,000 | |
| Exercise an Option | $25,500 | |
| Original award | $6,000 |
About this award
This is a $244,800 contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to RPK Associates, LLC, a small business. The contract is for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products for NIH drug discovery and development programs, including the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, and the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP). The contract has a one-year base period and one optional one-year period, and is set aside for small businesses under NAICS code 541690.
Quick answers
Who was awarded contract 75N95024P00130?
75N95024P00130 was awarded to RPK Associates, LLC by National Institute on Drug Abuse (National Institutes of Health) on February 15, 2024.
How much is contract 75N95024P00130 worth?
The government has obligated $67,500 on 75N95024P00130. Its potential value, with all options, is $244,800.
Which agency awarded contract 75N95024P00130?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00130, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95024P00130 competed?
The extent of competition for 75N95024P00130 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award